Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey
To access this article, please choose from the options below
A.D.L. has nothing to disclose. K.S. has nothing to disclose. C.V. has nothing to disclose. E.N. has nothing to disclose. C.A. has nothing to disclose. B.B. serves on the speakers' bureau for EMD Serono. R.C-D. has nothing to disclose. W.C.D. has nothing to disclose. E.G. has nothing to disclose. E.S.J. has nothing to disclose. P.G.M. has received grant support from Ferring and EMD Serono. E.R.M. is a consultant for Merck and GSK. B.O. has nothing to disclose. W.S. has performed sponsored research for Organon. J.S. is a consultant for Pfizer. J.A.T. has nothing to disclose. D.W. has nothing to disclose. R.R.F. has nothing to disclose. E.W. has nothing to disclose.
Supported by the Greenwall Foundation Presidential Award and Faculty Scholars Program; Duke Institute for Genome Sciences and Policy's Center for Genome Ethics, Law and Policy Research Fellowship Award; National Heart Lung and Blood Institute, the National Institutes of Health (1 K01 HL79517-01) [A.D.L.]; MREP Career Development Award from VA Health Services Research and Development (MRP 02-263 [K.S.], MRP04-216-1 [C.V.]); and NHGRI and U.S. Department of Energy (P50 HG003391) [R.C-D.].
PII: S0015-0282(08)04204-0
doi:10.1016/j.fertnstert.2008.10.015
© 2010 American Society for Reproductive Medicine. All rights reserved.

